Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Fish and Richardson
Cantor Fitzgerald
UBS
AstraZeneca
Argus Health
Dow
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017010

« Back to Dashboard

NDA 017010 describes DESONIDE, which is a drug marketed by G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Glenmark Pharms Ltd, and Hi-tech Pharmacal, and is included in thirteen NDAs. It is available from eleven suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
Summary for 017010
Tradename:DESONIDE
Applicant:Perrigo New York
Ingredient:desonide
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 017010
Medical Subject Heading (MeSH) Categories for 017010
Suppliers and Packaging for NDA: 017010
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESONIDE desonide CREAM;TOPICAL 017010 NDA Rebel Distributors Corp 42254-142 E 42254-142-15
DESONIDE desonide CREAM;TOPICAL 017010 NDA Perrigo New York Inc 45802-422 N 45802-422-35

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Colorcon
Argus Health
Express Scripts
Cipla
McKesson
Federal Trade Commission
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.